Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment could save trauma patients faster
Disease control Not yet recruitingThis study tests whether a new, shelf-stable blood product (IFC) can treat severe bleeding in injured patients faster than the standard product (Cryo-AHF). About 320 adults with traumatic injuries and low fibrinogen levels will receive one of the two treatments. The goal is to se…
Sponsor: Cerus Corporation • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Blood safety study: can antibodies to treated red cells trigger reactions?
Knowledge-focused Not yet recruitingThis study looks at whether people who have antibodies to specially treated red blood cells (INTERCEPT RBCs) might have a reaction when they receive a transfusion of these cells. Ten participants will be enrolled, some with and some without these antibodies. The goal is to unders…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 12:03 UTC